Literature DB >> 3911946

Characteristics of lipopolysaccharide interaction with human peripheral-blood monocytes.

S J Warner, N Savage, D Mitchell.   

Abstract

The interaction between radioiodinated lipopolysaccharide from Escherichia coli 0111:B4 (125I-LPS) and human peripheral-blood monocytes was studied. The association of 125I-LPS with monocytes at 37 degrees C appeared to depend on binding to the cell membrane with subsequent internalization of the molecule, and was not saturable with time (up to 2 h) or 125I-LPS concentration (up to 10 micrograms/ml). There was no apparent difference in the behaviour of unlabelled LPS and 125I-LPS with respect to monocyte association. 125I-LPS association with monocytes was inhibited by LPS and O-polysaccharide from E. coli 0111:B4 and Salmonella typhi 0901, but not by lipid A or polymyxin B. We propose that the mechanism of human monocyte stimulation by LPS involves polysaccharide-dependent binding to the cell membrane followed by internalization of the LPS molecule. We were unable to demonstrate a specific LPS receptor such as that found on murine B-lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3911946      PMCID: PMC1152890          DOI: 10.1042/bj2320379

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Genetic control of responses to bacterial lipopolysaccharides in mice. II. A gene that influences a membrane component involved in the activation of bone marrow-derived lymphocytes by lipipolysaccharides.

Authors:  J Watson; R Riblet
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

2.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

Review 3.  Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae.

Authors:  O Lüderitz; A M Staub; O Westphal
Journal:  Bacteriol Rev       Date:  1966-03

4.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

5.  Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms.

Authors:  C Galanos; O Lüderitz
Journal:  Eur J Biochem       Date:  1975-06

6.  Heterogeneity of lipopolysaccharides. Analysis of polysaccharide chain lengths by sodium dodecylsulfate-polyacrylamide gel electrophoresis.

Authors:  B Jann; K Reske; K Jann
Journal:  Eur J Biochem       Date:  1975-12-01

7.  Defective responses to lipid A in C3H/HeJ mice: approaches to an understanding of lipid A-cell interaction.

Authors:  S E Mergenhagen; D H Pluznik
Journal:  Rev Infect Dis       Date:  1984 Jul-Aug

8.  The interaction of Escherichia coli endotoxin with leukocytes.

Authors:  P E Gimber; G W Rafter
Journal:  Arch Biochem Biophys       Date:  1969-12       Impact factor: 4.013

9.  Effect of alkali-treated lipopolysaccharide on erythrocyte membrane stability.

Authors:  I Ciznár; J W Shands
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

10.  Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures.

Authors:  D C Morrison; L Leive
Journal:  J Biol Chem       Date:  1975-04-25       Impact factor: 5.157

View more
  3 in total

1.  Saturable CD14-dependent binding of fluorescein-labeled lipopolysaccharide to human monocytes.

Authors:  A Troelstra; P Antal-Szalmas; L A de Graaf-Miltenburg; A J Weersink; J Verhoef; K P Van Kessel; J A Van Strijp
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

2.  Inhibitory effect of 11 beta-hydroxypregna-1,4-diene-3,20-dione (delta HOP) on lymphocyte proliferation.

Authors:  C M Rondinone; R Schillaci; M B Castillo; A Roldán
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

3.  Antibody- and complement-dependent cell injury assayed by 51Cr release from human peripheral blood mononuclear cells pretreated with lipopolysaccharide.

Authors:  H Repo; M Leirisalo-Repo; M Nurminen; P H Mäkelä
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.